Placebo (B)
Placebo (B) is a dietary supplement with 10 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
71.4%
5 of 7 finished
28.6%
2 ended early
2
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers
A Study of INI-822 in Healthy Volunteers and Participants with Non-alcoholic Steatohepatitis (NASH) or Presumed NASH
Efficacy of Two Enzyme Cocktails in Healthy Adults
A Phase 1 Study of XH-S003 in Healthy Volunteers
A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Disease
Clinical Trials (10)
Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers
A Study of INI-822 in Healthy Volunteers and Participants with Non-alcoholic Steatohepatitis (NASH) or Presumed NASH
Efficacy of Two Enzyme Cocktails in Healthy Adults
A Phase 1 Study of XH-S003 in Healthy Volunteers
A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Disease
To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants
Pilot Study: Combining Nutritional Supplements With Standard Antidepressant to Treat Depression.
Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine
Glutamate Supplementation in Young Men
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
All 10 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 10